Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
Go back to Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration| (NASDAQ: GCTK) | Delayed: 0.29 -0.01 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $ | |||
| Open | $0.30 | 52 Week Low | $ | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.25 | EPS | $ | |||
| Volume | 22,716,347 | |||||
